跳至主要内容
临床试验/NCT03960905
NCT03960905Unknown不适用

A Study the Population Pharmacokinetics of Children Receiving the Anti-infective Drugs for Treatment of Infectious Disease in Central Nervous System

Wei Zhao1 个研究点 分布在 1 个国家目标入组 800 人开始时间: 2019年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
800
试验地点
1
主要终点
maximum concentration (Cmax)

研究概览

简要总结

The investigators aim to study the population pharmacokinetics of children receiving the anti-infective drugs for treatment of infectious disease in central nervous system.

详细描述

The investigators aim to study the population pharmacokinetics of children receiving the anti-infective drugs for treatment of infectious disease in central nervous system.In this study, the investigators will detect drug concentration in plasma by using residual blood samples of blood gas analysis and other clinical tests and employ computers for constructing population pharmacokinetic models.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
29 Days 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Children (29 days-18 years old) with anti-infective therapy against infectious disease in central nervous system.
  • Clinical symptoms: acute onset, fever (axillary temperature 38 ℃ or higher), headache, altered level of consciousness, vomiting, irritability, sleepiness, low muscle tone, seizures, before the fontanelle full or uplift, positive meningeal stimulation;
  • Aboratory examination: CSF appearance change, CSF routine WBC >100 per ml, CSF routine WBC 10-100 per ml, glucose <40mg/dl, protein >100mg/dl), positive detection of etiology (bacterial culture, antigen detection, gram staining).

排除标准

  • autoimmune encephalitis;
  • central nervous system infection complicated with tumor;
  • allergic to carbapenems or glycopeptide antibiotics;
  • other cases not suitable for enrollment (small sample size, incomplete clinical data, etc.).

结局指标

主要结局

maximum concentration (Cmax)

时间窗: up to 4 weeks

Cmax is a term used in pharmacokinetics refers to the maximum (or peak) serum concentration that a drug achieves in a specified compartment or test area of the body after the drug has been administrated and before the administration of a second dose.

次要结局

  • time to achieve maximum concentration (Tmax)(up to 4 weeks)

研究者

发起方
Wei Zhao
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Wei Zhao

Professor; Head of department of clinical pharmacy and pharmacology

Shandong University

研究点 (1)

Loading locations...

相似试验